Literature DB >> 21962475

Evaluation of hepatocellular carcinoma size using two-dimensional and volumetric analysis: effect on liver transplantation eligibility.

Mauricio Stanzione Galizia1, Hüseyin Gürkan Töre, Hamid Chalian, Vahid Yaghmai.   

Abstract

RATIONALE AND
OBJECTIVES: Milan criteria recommends selection of candidates with hepatocellular carcinoma (HCC) for liver transplantation based on strict tumor size thresholds. The purpose of this study is to compare the effect of two-dimensional and three-dimensional tumor measurements on the selection of candidates for liver transplantation using Milan criteria.
MATERIALS AND METHODS: This retrospective Health Insurance Portability and Accountability Act-compliant study was approved by our institutional review board. Patient-informed consent was waived. Forty-five HCCs in 19 patients, evaluated with triphasic multidetector row computed tomography scans, were included in the analysis. The largest diameters in each two-dimensional orthogonal plane (Max2D) and within three-dimensional tumor boundaries (Max3D) were calculated for each lesion. Diameters were compared and the eligibility based on lesion size for liver transplantation was assessed.
RESULTS: The mean Max2D diameter of HCC was 3.2 ± 0.9 cm and the mean Max3D diameter was 3.5 ± 1.2 cm. There was a significant difference between the mean Max2D and Max3D diameters (P < .001). Among the 45 lesions, 22 of them (48.9%) were ineligible for transplantation according to Max2D diameter, whereas 29 of them (64.44%) were ineligible when Max3D diameter was applied (P < .001).
CONCLUSION: HCC diameter based on 3D measurements is significantly different than the conventional 2D measurements and may affect eligibility for liver transplantation. Copyright Â
© 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21962475     DOI: 10.1016/j.acra.2011.08.011

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  8 in total

1.  Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.

Authors:  Sylvain Favelier; Louis Estivalet; Pierre Pottecher; Romaric Loffroy
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

Review 2.  Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.

Authors:  Bruno Hochhegger; Matheus Zanon; Stephan Altmayer; Gabriel S Pacini; Fernanda Balbinot; Martina Z Francisco; Ruhana Dalla Costa; Guilherme Watte; Marcel Koenigkam Santos; Marcelo C Barros; Diana Penha; Klaus Irion; Edson Marchiori
Journal:  Lung       Date:  2018-10-09       Impact factor: 2.584

3.  Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.

Authors:  Shin Hwang; Deok-Bog Moon; Ki-Hun Kim; Chul-Soo Ahn; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2020-09-19       Impact factor: 3.452

4.  Assessment of the response of hepatocellular carcinoma to interventional radiology treatments.

Authors:  Francesca Patella; Filippo Pesapane; Enrico Fumarola; Stefania Zannoni; Pietro Brambillasca; Ilaria Emili; Guido Costa; Victoria Anderson; Elliot B Levy; Gianpaolo Carrafiello; Bradford J Wood
Journal:  Future Oncol       Date:  2019-05-02       Impact factor: 3.404

5.  Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.

Authors:  Shin Hwang; Gi-Won Song; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2016-06-16       Impact factor: 3.452

6.  Specific CT 3D rendering of the treatment zone after Irreversible Electroporation (IRE) in a pig liver model: the "Chebyshev Center Concept" to define the maximum treatable tumor size.

Authors:  Dominik Vollherbst; Stefan Fritz; Sascha Zelzer; Miguel F Wachter; Maya B Wolf; Ulrike Stampfl; Daniel Gnutzmann; Nadine Bellemann; Anne Schmitz; Jürgen Knapp; Philippe L Pereira; Hans U Kauczor; Jens Werner; Boris A Radeleff; Christof M Sommer
Journal:  BMC Med Imaging       Date:  2014-01-10       Impact factor: 1.930

7.  Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.

Authors:  Ye Ra Choi; Jung Hoon Kim; Sang Joon Park; Bo Yun Hur; Joon Koo Han
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

8.  Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database.

Authors:  Gil-Chun Park; Shin Hwang; Yo-Han Park; Jin-Uk Choi
Journal:  Ann Surg Treat Res       Date:  2020-04-28       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.